| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.21 | 9e-10 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.19 | 1e-09 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.23 | 1e-09 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | 0.23 | 2e-09 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.2 | 2e-09 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | 0.2 | 2e-09 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | 0.2 | 3e-09 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | 0.19 | 3e-09 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.18 | 6e-09 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.2 | 7e-09 |